Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Epidermal growth factor receptor [695-1022,T790M,C797S,L858R] | ||
Ligand | BDBM525486 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Biochemical EGFR Inhibition Assays (5 mM ATP) | ||
IC50 | 0.800±n/a nM | ||
Citation | Boese, D; Dahmann, G; Engelhardt, H; Petronczki, M; Scharn, D Benzimidazole compounds and derivatives as EGFR inhibitors US Patent US11174245 Publication Date 11/16/2021 | ||
More Info.: | Get all data from this article, Assay Method | ||
Epidermal growth factor receptor [695-1022,T790M,C797S,L858R] | |||
Name: | Epidermal growth factor receptor [695-1022,T790M,C797S,L858R] | ||
Synonyms: | EGFR | EGFR (aa 695-1022, L858R, T790M, C797S) | EGFR_HUMAN | ERBB | ERBB1 | HER1 | ||
Type: | Enzyme Catalytic Domain | ||
Mol. Mass.: | 37397.86 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P00533[695-1022,T790M,C797S,L858R] | ||
Residue: | 328 | ||
Sequence: |
| ||
BDBM525486 | |||
n/a | |||
Name | BDBM525486 | ||
Synonyms: | US11174245, # I-136 | US11174245, # I-138 | ||
Type | Small organic molecule | ||
Emp. Form. | C24H23N7O2 | ||
Mol. Mass. | 441.4851 | ||
SMILES | Cn1cc(cn1)-c1cc(cc(n1)C#N)C(=O)\N=c1/[nH]c2ccccc2n1[C@@H]1CC[C@H](O)CC1 |r,wU:26.29,29.33,(5.75,-4.31,;5.75,-2.77,;4.5,-1.87,;4.98,-.4,;6.52,-.4,;6.99,-1.87,;4.21,.93,;2.67,.93,;1.9,2.26,;2.67,3.6,;4.21,3.6,;4.98,2.26,;4.98,4.93,;5.75,6.27,;.36,2.26,;-.41,3.6,;-.41,.93,;-1.95,.93,;-2.86,2.18,;-4.32,1.7,;-5.66,2.47,;-6.99,1.7,;-6.99,.16,;-5.66,-.61,;-4.32,.16,;-2.86,-.32,;-2.46,-1.8,;-3.55,-2.89,;-3.15,-4.38,;-1.66,-4.78,;-1.27,-6.27,;-.57,-3.69,;-.97,-2.2,)| | ||
Structure |